Kazmierczak, Philipp M <br/><br/>
Integrin-targeted quantitative optoacoustic imaging with MRI correlation for monitoring a BRAF/MEK inhibitor combination therapy in a murine model of human melanoma.  [electronic resource] 

 -  PloS one  2018 
 - e0204930 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0204930  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Benzimidazoles--administration & dosage<br/>Carbamates--administration & dosage<br/>Cell Line, Tumor<br/>Humans<br/>Integrin alphaVbeta3--metabolism<br/>Magnetic Resonance Imaging<br/>Melanoma--diagnostic imaging<br/>Mice<br/>Mice, Nude<br/>Molecular Imaging<br/>Mutation<br/>Photoacoustic Techniques--methods<br/>Proto-Oncogene Proteins B-raf--genetics<br/>Sulfonamides--administration & dosage<br/>Treatment Outcome<br/>Xenograft Model Antitumor Assays